Carl L. Gordon - Insider Trading & Ownership

Location
601 Lexington Avenue, 54 Th Floor, New York, NY
Summary
The estimated net worth of Carl L. Gordon is at least $34.6M dollars as of June 6, 2025. Carl L. Gordon is the Director of Venetian-1 Acquisition Corp. and owns shares of Lomond Therapeutics Holdings, Inc. stock worth about $10.7M. Carl L. Gordon is the Director, 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $8.11M. Carl L. Gordon is the Director, 10%+ Owner of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $7.56M. Carl L. Gordon is the Director, 10%+ Owner of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $5.52M. Carl L. Gordon is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $1.8M. Carl L. Gordon is the Director, 10%+ Owner of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $942K.
Signature
/s/ Keith Regnante, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Carl L. Gordon

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NONE Lomond Therapeutics Holdings, Inc. Director $10.7M Nov 1, 2024
MBX MBX Biosciences, Inc. Director, 10%+ Owner $8.11M +$2.02M +33.2% Feb 14, 2025
TERN Terns Pharmaceuticals, Inc. Director, 10%+ Owner $7.56M Jul 15, 2024
AVBP ArriVent BioPharma, Inc. Director, 10%+ Owner $5.52M Jan 30, 2024
KROS Keros Therapeutics, Inc. Director $1.8M Jun 4, 2025
ACET Adicet Bio, Inc. Director, 10%+ Owner $942K Aug 21, 2024
CMPX Compass Therapeutics, Inc. Director, 10%+ Owner $0 -$5.68M -100% Apr 9, 2025
KNTE Kinnate Biopharma Inc. Director, 10%+ Owner $0 Apr 3, 2024
THRX Theseus Pharmaceuticals, Inc. Director, 10%+ Owner $0 Feb 14, 2024
IRON Disc Medicine, Inc. Director, 10%+ Owner Oct 4, 2021
ORIC Oric Pharmaceuticals, Inc. Director, 10%+ Owner Jun 16, 2021

Insider Transactions Reported by Carl L. Gordon:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.